Aerie Pharmaceuticals, Inc. (AERI) was a big mover last session, as the company saw its shares rise over 8% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $16.73 to $26.98 in the past one-month time frame, showed a pick-up yesterday at $26.40.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Aerie Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other attractive players in the healthcare industry include Synergy Pharmaceuticals, Inc. (SGYP), carrying a Zacks Rank #1 (Strong Buy) along with BioCryst Pharmaceuticals, Inc. (BCRX) and Ohr Pharmaceutical, Inc. (OHRP) with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
SYNERGY PHARMACEUTICALS DE (SGYP): Free Stock Analysis Report
AERIE PHARMACEUTICALS INC (AERI): Free Stock Analysis Report
OHR PHARMACEUTICAL INC (OHRP): Free Stock Analysis Report
BIOCRYST PHARMACEUTICALS INC (BCRX): Free Stock Analysis Report
Zacks Investment Research
Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock up 8.37%
Terms and Privacy Policy